Sen. Elizabeth Warren (D-Mass.) was one of the organizers of a congressional Democratic letter to PhRMA inquiring about "rapid price hikes affecting the vast majority of popular brand name drugs.”
Congressional Democrats Confront PhRMA About Brand Drug Price Hikes
Thirteen congressional Democrats—eight senators and five representatives—asked Pharmaceutical Research and Manufacturers of America (PhRMA) to respond by March 8 to questions about “rapid price hikes affecting the vast majority of popular brand name drugs.”
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
